Peirson Leslea, Douketis James, Ciliska Donna, Fitzpatrick-Lewis Donna, Ali Muhammad Usman, Raina Parminder
McMaster Evidence Review and Synthesis Centre, Hamilton, Ont.
Department of Medicine, McMaster University, Hamilton, Ont. ; St. Joseph's HealthCare Hamilton, Hamilton, Ont.
CMAJ Open. 2014 Oct 1;2(4):E268-72. doi: 10.9778/cmajo.20140019. eCollection 2014 Oct.
The prevalence of normal-weight adults is decreasing, and the proportion in excessive weight categories (body mass index ≥ 25) is increasing. In this review, we sought to identify interventions to prevent weight gain in normal-weight adults.
We searched multiple databases from January 1980 to June 2013. We included randomized trials of primary care-relevant behavioural, complementary or alternative interventions for preventing weight gain in normal-weight adults that reported weight change at least 12 months after baseline. We included any studies reporting harms. We planned to extract and pool data for 4 weight outcomes, 6 secondary health outcomes and 5 adverse events categories.
One small study provided moderate-quality evidence. The 12-month program, which used education and financial strategies and was offered more than 25 years ago in the United States, was successful in stabilizing weight and producing weight loss. More intervention participants maintained their baseline weight or lost weight than controls (82% v. 56%, p < 0.0001), and program participants maintained their weight better than controls by showing greater weight reduction by the end of the intervention (mean difference adjusted for height -0.82, 95% confidence interval -1.57 to -0.06, kg). No evidence was available for sustained effects or for any other weight outcomes, secondary outcomes or harms.
We were unable to determine whether behavioural interventions led to weight-gain prevention and improved health outcomes in normal-weight adults. Given the importance of primary prevention, and the difficulty of losing weight and maintaining weight loss, this paucity of evidence is surprising and leaves clinicians and public health practitioners with unclear direction.
PROSPERO no. CRD42012002753.
正常体重成年人的比例在下降,而超重类别(体重指数≥25)的比例在上升。在本综述中,我们试图确定预防正常体重成年人体重增加的干预措施。
我们检索了1980年1月至2013年6月的多个数据库。我们纳入了与初级保健相关的行为、补充或替代干预措施的随机试验,这些干预措施用于预防正常体重成年人的体重增加,且报告了基线后至少12个月的体重变化。我们纳入了任何报告有害影响的研究。我们计划提取并汇总4个体重结局、6个次要健康结局和5个不良事件类别的数据。
一项小型研究提供了中等质量的证据。该为期12个月的项目采用了教育和经济策略,25多年前在美国实施,成功地稳定了体重并实现了体重减轻。与对照组相比,更多的干预参与者维持了基线体重或减轻了体重(82%对56%,p<0.0001),并且项目参与者在干预结束时体重减轻更多,从而比对照组更好地维持了体重(根据身高调整的平均差异为-0.82,95%置信区间为-1.57至-0.06,千克)。没有证据表明有持续效果或任何其他体重结局、次要结局或有害影响。
我们无法确定行为干预是否能预防正常体重成年人的体重增加并改善健康结局。鉴于一级预防的重要性,以及减肥和维持体重减轻的困难,证据的匮乏令人惊讶,这让临床医生和公共卫生从业者方向不明。
PROSPERO编号CRD42012002753。